February 14, 2025 – The Tim Huston government in Nova Scotia has announced the province’s largest ever capital plan, with more than $1 -billion earmarked for health care projects. The… Read More
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025 NORTH CHICAGO, ILL – AbbVie (NYSE: ABBV) announced that its board of directors has unanimously elected chief executive… Read More
Ojjaara received a reimburse recommendation from Canada’s Drug Agency, a decisive achievement in advancing access to rare blood cancer treatments. MISSISSAUGA, ON – Ojjaara (momelotinib) has received a reimburse with conditions recommendation from Canada’s… Read More
Agreement on Formulation and Finish of a Virus-Like Particle Vaccine for Phase 1 and 2 Clinical Trials MONTREAL, QC & QUEBEC CITY, QC – Aramis Biotechnologies Inc. (“Aramis”), Quebec City-based… Read More
Fabhalta® is the first oral monotherapy for previously treated and treatment-naïve adults with paroxysmal nocturnal hemoglobinuria (PNH)1,2 Significant unmet need remains in PNH, a chronic, rare and potentially life-threatening blood… Read More
